Abstract
The Scandinavian (Nordic) countries are Denmark, Finland, Iceland, Norway and Sweden, with a combined total population of approximately 23 millions and an annual number of new breast cancer patients of approximately 12000. The health care systems are very similar in the Scandinavian countries and virtually all cancer patient care occurs within the framework of the public health care system.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bergkvist L, Adami H-O, Persson I (1989) Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestin replacement therapy. Am J Epidemiol 139:221–228
Dhodapka MV, Ingle JN, Ahmann DL (1995) Estrogen replacement therapy withdrawal and regression of metastatic breast cancer. Cancer 75:43–46
Early Breast Cancer Trialists’ Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339:1–15, 71-85
Hortobagyi GN, Therialt RL, Porter L, Blayney D, Lipton A, Sinoff C, Wheeler H, Simeone JF, Seaman J, Knight RD, Heffernan M, Reitsma DJ (1996) Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N Engl J Med 335:1785–1791
Mouridsen HT (1996) The role of anthracyclines in adjuvant chemotherapy of breast cancer: a critical appraisal. Recent Results Cancer Res 127:191–199
Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach M, Kjær M, Gadeberg CC, Mouridsen HT, Jensen M-B, Zedeler K (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337:949–955
Roy JA, Sawka CA, Pritchard KI (1996) Hormone replacement therapy in women with breast cancer: do the risks outweigh the benefits? J Clin Oncol 14:997–1006
Scottish Cancer Trials Breast Group, ICRF Breast Unit (1993) Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: the Scottish trial. Lancet 341:1294–1298
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Mouridsen, H.T. (1998). Nordic Trials of Adjuvant Therapy in Primary Breast Cancer. In: Senn, HJ., Gelber, R.D., Goldhirsch, A., Thürlimann, B. (eds) Adjuvant Therapy of Primary Breast Cancer VI. Recent Results in Cancer Research, vol 152. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45769-2_42
Download citation
DOI: https://doi.org/10.1007/978-3-642-45769-2_42
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-45771-5
Online ISBN: 978-3-642-45769-2
eBook Packages: Springer Book Archive